Collegium Pharmaceutical Inc. Revenue 2016–2025
Collegium Pharmaceutical Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Collegium Pharmaceutical Inc. revenue for the quarter ending March 31, 2026 was 193.5 M, a 8.87% increase year-over-year.
- Collegium Pharmaceutical Inc. revenue for the twelve months ending March 31, 2026 was 768.6 M, a 31.12% increase year-over-year.
- Collegium Pharmaceutical Inc. annual revenue for 2025 was 780.6 M, a 23.62% increase from 2024.
- Collegium Pharmaceutical Inc. annual revenue for 2024 was 631.4 M, a 11.41% increase from 2023.
- Collegium Pharmaceutical Inc. annual revenue for 2023 was 566.8 M, a 22.17% increase from 2022.
- Collegium Pharmaceutical Inc. annual revenue for 2022 was 463.9 M.
Collegium Pharmaceutical Inc. (COLL) — Frequently Asked Questions
Collegium Pharmaceutical Inc. (COLL) is a publicly traded US company. It has a market capitalization of $1.36B. In fiscal 2025 it reported revenue of $781M and net income of $63M. Explore COLL's stock price, financial statements, earnings history, margins and key ratios below.
What is Collegium Pharmaceutical Inc.'s market cap?
Collegium Pharmaceutical Inc. (COLL) has a market capitalization of $1.36B.
What is the COLL stock price?
COLL trades at $34.29 (-1.47% on the day).
How much revenue does Collegium Pharmaceutical Inc. make?
Collegium Pharmaceutical Inc. reported revenue of $781M in fiscal 2025.
Is COLL profitable?
In fiscal 2025, Collegium Pharmaceutical Inc. reported net income of $63M.